Surgery

Search results

• Collegium Pharmaceutical jumps 71% in past year, outperforming 87% of the market

  Thomas, M.

  7/10/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding soars 92% in past year, outperforming 94% of the market

  Thomas, M.

  7/10/24

  1 item of Media coverage

  Press/Media

• Area residents graduate from 2024 Kansas Hospital Association Leadership Institute

  Thomas, M.

  3/10/24

  1 item of Media coverage

  Press/Media

• Q3/2024: Monthly: Biohaven Pharmaceutical Holding (BHVN: $49.97) in top 3% performers of NYSE market in past quarter

  Thomas, M.

  1/10/24

  1 item of Media coverage

  Press/Media

• Monthly: Collegium Pharmaceutical (COLL: $38.64) increases on thin volume in September 2024

  Thomas, M.

  1/10/24

  1 item of Media coverage

  Press/Media

• KHA Leadership Institute graduates 30

  Thomas, M.

  30/09/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical climbs 19% in 2024, outperforming Medical/Drugs sector

  Thomas, M.

  13/09/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding sinks 16% in 2024, underperforming 81% of the market

  Thomas, M.

  13/09/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding decreases 7.9% in 2024

  Thomas, M.

  3/09/24

  1 item of Media coverage

  Press/Media

• Monthly: Biohaven Pharmaceutical Holding (BHVN: $39.40) rises on high volatility in August 2024

  Thomas, M.

  3/09/24

  2 items of Media coverage

  Press/Media

• Collegium Pharmaceutical surges 63% in past year, outperforming 87% of the market

  Thomas, M.

  3/09/24

  2 items of Media coverage

  Press/Media

• Collegium Pharmaceutical jumps 25% in 2024

  Thomas, M.

  3/09/24

  1 item of Media coverage

  Press/Media

• Monthly: Biohaven Pharmaceutical Holding (BHVN: $39.40) rises on high volatility in August 2024

  Thomas, M.

  30/08/24

  1 item of Media coverage

  Press/Media

• Monthly: Collegium Pharmaceutical (COLL: $38.46) falls on below average volume in August 2024

  Thomas, M.

  30/08/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical climbs 15% in 2024, outperforming Medical/Drugs sector

  Thomas, M.

  9/08/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding sinks 14% in 2024

  Thomas, M.

  9/08/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical jumps 25% in 2024, outperforming 81% of the market

  Thomas, M.

  5/08/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical surges 69% in past year, outperforming 92% of the market

  Thomas, M.

  5/08/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding soars 98% in past year, outperforming 97% of the market

  Thomas, M.

  5/08/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding sinks 8.1% in 2024

  Thomas, M.

  5/08/24

  1 item of Media coverage

  Press/Media

• Monthly: Collegium Pharmaceutical (COLL: $38.57) surges 20% on average volume in July 2024

  Thomas, M.

  1/08/24

  1 item of Media coverage

  Press/Media

• Monthly: Biohaven Pharmaceutical Holding (BHVN: $39.33) jumps 13% on thin volume in July 2024

  Thomas, M.

  1/08/24

  1 item of Media coverage

  Press/Media

• Monthly: Biohaven Pharmaceutical Holding (BHVN: $39.33) up 13% on thin volume in July 2024

  Thomas, M.

  31/07/24

  1 item of Media coverage

  Press/Media

• Monthly: Collegium Pharmaceutical (COLL: $38.57) up 20% on average volume in July 2024

  Thomas, M.

  31/07/24

  1 item of Media coverage

  Press/Media

• Study Findings from Oklahoma State University Center for Health Sciences Update Knowledge in COVID-19 (Preference signaling in orthopaedic surgery: applicant perspectives and opinions)

  Hughes, G. & Hanson, C.

  19/07/24

  1 item of Media coverage

  Press/Media